Drug recall · June 1, 2022
NB-343 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 30 mcg/mL recall
Why: Lack of assurance of sterility.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
NB-343 Papaverine 30 mg/mL Phentolamine 3 mg/mL PGE 30 mcg/mL, Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0010-10.
- Lots / codes
Lot: L24C08 BUD: 12/8/2022
- Quantity
- 606 vials
- Company
- Olympia Compounding Pharmacy dba Olympia Pharmacy, Orlando, FL
- Distribution
- Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands
- Initiated
- May 9, 2022 · Voluntary: Firm initiated
- Classified
- May 25, 2022
- Reported
- June 1, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Papaverine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.